Anthony de Padova
Basking Ridge, NJNPI 1790959229
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $899,255 of the $899,255 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Boehringer Ingelheim. Reporting peaked in 2021 at $274,595 and has fallen 98.2% since, to $5,003 in 2025.
$899,255in general payments, 2019–2025
Across 21 payments — averaging $42,822 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$899K
What the payments were for
- Consulting fees$899,255100%
General payments by program year
19
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 21 | $899,255 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.